To include your compound in the COVID-19 Resource Center, submit it here.

MDX-066: Final Phase II data

Final data from the double-blind, U.S. and Canadian Phase II CA-GCDX-06-02 trial in 200 patients receiving standard of care antibiotics metronidazole or vancomycin showed that a single IV

Read the full 288 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE